News
Indian retail investors ramped up US stock purchases amid global market volatility, with a strong tilt toward semiconductors, ...
1h
Zacks Investment Research on MSNISRG's Vessel Sealer Curved for da Vinci Systems Gets FDA ApprovalIntuitive Surgical ISRG recently received FDA clearance for its Vessel Sealer Curved, a multifunctional instrument designed ...
HIMS benefits from strong online revenue, subscriber growth, and global expansion moves to fuel its health platform momentum. However, challenges may hurt performance.
Executives and directors of Hims & Hers Health Inc., a leading telehealth company, are facing a shareholder derivative ...
Digging Into the Bargain Bin Investing in beaten-down stocks can be a savvy strategy for long-term wealth creation, as it ...
The company will offer a generic version of semaglutide in the country after Novo Nordisk let its patent expire there. Hims & ...
Explore more
Hims & Hers (HIMS) stock in focus as the company faces a growing number of lawsuits following Novo Nordisk's (NVO) decision ...
Hims & Hers Health is a top telehealth company with strong growth, innovation, and global expansion plans. See more on HIMS ...
Hims & Hers Health, Inc. (NYSE:HIMS) is among the 13 Best Booming Stocks to Buy Now. On July 9, the digital health and ...
Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories.
Hims & Hers Health Inc. board members and executives failed to tell shareholders that its Novo Nordisk A/S Wegovy ...
Telehealth company Hims & Hers is facing a growing number of U.S. investor lawsuits after Novo Nordisk's decision last month to end a short-lived partnership to sell its Wegovy weight-loss drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results